SBI Securities’s Spero Therapeutics SPRO Stock Holding History
Bought
Maintained
Sold
Other funds holding SPRO
SBI Securities's SPRO Position: Q3 2026 in Review
SBI Securities increased its Spero Therapeutics (SPRO) stake by 369% in Q3 2026, buying an estimated $65 and bringing the position to 61 shares worth $74. The position accounts for ﹤0.01% of the portfolio, ranked #3654.
SBI Securities first reported a position in SPRO in Q4 2024 and has held it in 8 quarters since. The position peaked at $219 in Q4 2024. 61 funds tracked by Wall St. Rank hold SPRO as of Q3 2026.
- SBI Securities held 61 shares of Spero Therapeutics worth $74 as of Q3 2026.
- SBI Securities bought 48 Spero Therapeutics shares in Q3 2026, an estimated $65.
- Spero Therapeutics made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #3654 holding.
- SBI Securities first reported a position in Spero Therapeutics in Q4 2024 and has held it in 8 quarters since.
- SBI Securities's Spero Therapeutics position peaked at $219 in Q4 2024.
- 61 funds tracked by Wall St. Rank held Spero Therapeutics as of Q3 2026.
Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.